Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works

The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease

(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747 · see citing works

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions

Burstein, M., Scholnick, H. R., & Morfin, R. F. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42943-8 · Cited by 2,500 · see citing works

Apolipoprotein E polymorphism and atherosclerosis.

Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981 · see citing works

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · see citing works

Atherogenesis: a postprandial phenomenon.

Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654 · see citing works

Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum

Burstein, M., & Samaille, J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90075-9 · Cited by 620 · see citing works

Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis

Arntzenius, A. C., Kromhout, D., Barth, J. D., Reiber, J. H. C., Bruschke, A. V. G., Buis, B., van Gent, C. M., Kempen-Voogd, N., Strikwerda, S., & van der Velde, E. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121301 · Cited by 498 · see citing works

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Brown, W. V., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 493 · see citing works

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

Levy, R. I., Brensike, J. F., Epstein, S. E., Kelsey, S. F., Passamani, E. R., Richardson, J. M., Loh, I. K., Stone, N. J., Aldrich, R. F., & Battaglini, J. W. (1984) · Circulation · doi:10.1161/01.cir.69.2.325 · Cited by 437 · see citing works

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424 · see citing works

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414 · see citing works

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

Soutar, A. K., Garner, C. W., Baker, H. N., Sparrow, J. T., Jackson, R. L., Gotto, A. M., & Smith, L. C. (1975) · Biochemistry · doi:10.1021/bi00685a003 · Cited by 392 · see citing works

Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins.

Windler, E., Chao, Y., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70647-4 · Cited by 365 · see citing works

Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

Shelburne, F. A., Hanks, J., Meyers, W., & Quarfordt, S. H. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109710 · Cited by 358 · see citing works

Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man

Kuusi, T., Saarinen, P., & Nikkilä, E. A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90251-8 · Cited by 336 · see citing works

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

Windler, E. E. T., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314 · see citing works

Role of Specific Glycopeptides of Human Serum Lipoproteins in the Activation of Lipoprotein Lipase

Havel, R. J., Shore, V. G., SHORE, B., & Bier, D. M. (1970) · Circulation Research · doi:10.1161/01.res.27.4.595 · Cited by 310 · see citing works

Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

Curry, M. D., Alaupovic, P., & Suenram, C. A. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.3.315 · Cited by 286 · see citing works

Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B.

Curry, M. D., Gustafson, A., Alaupovic, P., & McConathy, W. J. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.2.280 · Cited by 172 · see citing works

Quantitative determination of human apolipoprotein Cc-III by electroimmunoassay

Curry, M. D., McConathy, W. J., Fesmire, J. D., & Alaupovic, P. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90016-8 · Cited by 140 · see citing works

Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia

Carlson, L. A., & Ballantyne, D. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90016-2 · Cited by 139 · see citing works

Dynamics of apolipoprotein E metabolism in humans

Blum, C. B. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38036-6 · Cited by 136 · see citing works

The Cholesterol Lowering Atherosclerosis Study (CLAS): Design, methods, and baseline results

Blankenhorn, D. H., Johnson, R. L., Nessim, S., Azen, S. P., Sanmarco, M. E., & Selzer, R. H. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90156-5 · Cited by 118 · see citing works

Independent regulation of plasma apolipoprotein C–II and C–III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins

Le, N. A., Gibson, J. C., & Ginsberg, H. N. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38512-6 · Cited by 103 · see citing works

David Rubinstein Memorial Lecture: The biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins

Alaupovic, P. (1981) · Canadian Journal of Biochemistry · doi:10.1139/o81-079 · Cited by 69 · see citing works

Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias.

Alaupovic, P., Wj, M., Fesmire, J. D., Tavella, M. J., & Bard, J. (1988) · PubMed · Cited by 66 · see citing works

Lipoproteins and lipoprotein metabolism

Eisenberg, S. (1983) · Journal of Molecular Medicine · doi:10.1007/bf01486366 · Cited by 54 · see citing works

Postprandial exchange of apolipoprotein C-III between plasma lipoproteins

Barr, S. I., Kottke, B. A., & Mao, S. J. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.2.191 · Cited by 30 · see citing works

Isolation of apolipoprotein-free lipoprotein lipase from human post-heparin plasma

Ganesan, D., & Bradford, R. H. (1971) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(71)90648-6 · Cited by 24 · see citing works

Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works

The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events

Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · see citing works

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state

Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122 · see citing works

Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events

Robins, S. J., Collins, D. E., Wittes, J. T., Papademetriou, V., DEEDWANIA, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., WEXLER, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 916 · see citing works

Metabolic origins and clinical significance of LDL heterogeneity

Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896 · see citing works

Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction

Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., Breslow, J. L., & Buring, J. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2520 · Cited by 602 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Fruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463 · see citing works

Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

Walldius, G., & Jungner, I. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01276.x · Cited by 395 · see citing works

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

Frick, M., Syvänne, M., Nieminen, M., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y., Pasternack, A., & Taskinen, M. R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 409 · see citing works

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.

Salonen, J. T., Salonen, R. M., Seppänen, K., Rauramaa, R., & Tuomilehto, J. O. (1991) · Circulation · doi:10.1161/01.cir.84.1.129 · Cited by 360 · see citing works

Lipoprotein Metabolism and Renal Failure

Attman, P., Samuelsson, O. G., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 356 · see citing works

Atherosclerosis and arteriosclerosis in chronic renal failure

London, G. M., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.233 · Cited by 352 · see citing works

Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media

Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334 · see citing works

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321 · see citing works

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070308 · Cited by 282 · see citing works

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

Fruchart, J.-C., Sacks, F. M., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.046 · Cited by 260 · see citing works

Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins

Zilversmit, D. B. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.153 · Cited by 262 · see citing works

New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism

Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255 · see citing works

Coronary bypass graft fate: Long-term angiographic study

FitzGibbon, G. M., Leach, A. J., Kafka, H. P., & Keon, W. J. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90834-v · Cited by 234 · see citing works

Atherogenicity of Triglyceride-Rich Lipoproteins

Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227 · see citing works

Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.

Salonen, J. T., Salonen, R. M., Seppänen, K., Kantola, M., Suntioinen, S., & Korpela, H. (1991) · BMJ · doi:10.1136/bmj.302.6779.756 · Cited by 205 · see citing works

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

Fruchart‐Najib, J., Baugé, E., Niculescu, L. S., Pham, T., Thomas, B., Rommens, C., Majd, Z., Brewer, B., Pennacchio, L. A., & Fruchart, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.003 · Cited by 198 · see citing works

Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells

Kawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F. W., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591743 · Cited by 206 · see citing works

The Influence of Diet on the Appearance of New Lesions in Human Coronary Arteries

Blankenhorn, D. H. (1990) · JAMA · doi:10.1001/jama.1990.03440120068039 · Cited by 191 · see citing works

Laboratory Assessment of HDL Heterogeneity and Function

Movva, R., & Rader, D. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101923 · Cited by 187 · see citing works

Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors

Fuster, V., Gotto, A. M., Libby, P., Loscalzo, J., & McGill, H. C. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00014-9 · Cited by 186 · see citing works

The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial

Alaupovic, P., Mack, W. J., Knight‐Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184 · see citing works

Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)

Mack, W. J., Krauss, R. M., & Hodis, H. N. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.5.697 · Cited by 173 · see citing works

Effects of colestipol-niacin therapy on human femoral atherosclerosis.

Blankenhorn, D. H., Azen, S. P., Crawford, D. W., Nessim, S., Sanmarco, M. E., Selzer, R. H., Shircore, A. M., & Wickham, E. (1991) · Circulation · doi:10.1161/01.cir.83.2.438 · Cited by 172 · see citing works

A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity

Seshadri, P., Iqbal, N., Stern, L., Williams, M., Chicano, K. L., Daily, D. A., McGrory, J., Gracely, E. J., Rader, D. J., & Samaha, F. F. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.009 · Cited by 169 · see citing works

Minimum heart rate and coronary atherosclerosis: Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age

Perski, A., Olsson, G., Landou, C., Fairé, U. D., Theorell, T., & Hamsten, A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90497-j · Cited by 166 · see citing works

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

Miller, B., Alderman, E., Haskell, W., Fair, J., & Krauss, R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2146 · Cited by 176 · see citing works

Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease

Brewer, H. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00308-2 · Cited by 157 · see citing works

Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins

Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156 · see citing works

Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation

Ferrières, J., Lambert, J., Lussier‐Cacan, S., & Davignon, J. (1995) · Circulation · doi:10.1161/01.cir.92.3.290 · Cited by 154 · see citing works

Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen

Harjai, K. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00009 · Cited by 150 · see citing works

Triglyceride-Rich Lipoprotein Remnant Particles and Risk of Atherosclerosis

Hodis, H. N. (1999) · Circulation · doi:10.1161/01.cir.99.22.2852 · Cited by 149 · see citing works

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

Watts, G. F., Mandalia, S., Brunt, J. N. H., Slavin, B. M., COLTART, D. J., & Lewis, B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90199-x · Cited by 146 · see citing works

Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease

Jensen, M. K., Rimm, E. B., Furtado, J. D., & Sacks, F. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000232 · Cited by 142 · see citing works

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300253-jlr200 · Cited by 139 · see citing works

Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery

Kulik, A., Brookhart, M. A., Levin, R., Ruel, M., Solomon, D. H., & Choudhry, N. K. (2008) · Circulation · doi:10.1161/circulationaha.108.799445 · Cited by 137 · see citing works

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

Mendivil, C. O., Rimm, E. B., Furtado, J., Chiuve, S. E., & Sacks, F. M. (2011) · Circulation · doi:10.1161/circulationaha.111.056986 · Cited by 136 · see citing works

Triglycerides and Coronary Risk in Women and the Elderly

LaRosa, J. C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440300051004 · Cited by 136 · see citing works

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Onat, A., Hergenç, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., & Assmann, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00025-x · Cited by 134 · see citing works

Predicting requirement change propagation, using higher order design structure matrices: an industry case study

Morkos, B. W., Shankar, P., & Summers, J. D. (2012) · Journal of Engineering Design · doi:10.1080/09544828.2012.662273 · Cited by 129 · see citing works

Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

Cabezas, M. C., de Bruin, T. W. A., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.804 · Cited by 123 · see citing works

Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study

Russo, G. T., Meigs, J. B., Cupples, L. A., Demissie, S., Otvos, J. D., Wilson, P. W. F., Lahoz, C., Cucinotta, D., Couture, P., Mallory, T., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00409-9 · Cited by 123 · see citing works

The Asp 9 Asn Mutation in the Lipoprotein Lipase Gene Is Associated With Increased Progression of Coronary Atherosclerosis

Jukema, J. W., Boven, A. J. V., Groenemeijer, B. E., Zwinderman, A. H., Reiber, J. H. C., Bruschke, A. V. G., Henneman, J. A., Molhoek, G. P., Bruin, T., Jansen, H., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1913 · Cited by 123 · see citing works

Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases

Koba, S., Hirano, T., Ito, Y., Tsunoda, F., Yokota, Y., Ban, Y., Iso, Y., Suzuki, H., & Katagiri, T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.002 · Cited by 121 · see citing works

Beyond LDL Cholesterol Reduction

Superko, H. R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2351 · Cited by 119 · see citing works

Triglycerides: a risk factor for coronary heart disease

Davignon, J., & Cohn, J. S. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05858-3 · Cited by 115 · see citing works

Apolipoprotein C-III

Kohan, A. B. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000136 · Cited by 113 · see citing works

Gene-diet interaction in determining plasma lipid response to dietary intervention

Ordovás, J. M., López‐Miranda, J., Mata, P., Pérez‐Jiménez, F., Lichtenstein, A. H., & Schaefer, E. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)90069-1 · Cited by 114 · see citing works

Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions

Fredenrich, A., Giroux, L.-M., Tremblay, M., Krimbou, L., Davignon, J., & Cohn, J. S. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37424-1 · Cited by 114 · see citing works

[2] Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

Alaupovic, P. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63004-3 · Cited by 110 · see citing works

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts

Jensen, M. K., Aroner, S. A., Mukamal, K. J., Furtado, J. D., Post, W. S., Tsai, M. Y., Tjønneland, A. M., Polak, J. F., Rimm, E. B., Overvad, K., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031276 · Cited by 105 · see citing works

Metabolic abnormalities: triglyceride and low-density lipoprotein

Krauss, R. M., & Siri, P. W. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.016 · Cited by 102 · see citing works

Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis

Koba, S., Yokota, Y., Hirano, T., Ito, Y., Ban, Y., Tsunoda, F., Sato, T., Shoji, M., Suzuki, H., Geshi, E., et al. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e572 · Cited by 102 · see citing works

Lipid and apolipoprotein abnormalities in hirsute women

Wild, R. A., Alaupovic, P., & Parker, I. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90605-x · Cited by 102 · see citing works

Apolipoproteins C–III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Temoins sur 'Infarctus du Myocarde

Luc, G., Fievet, C., Arveiler, D., Evans, A. E., Bard, J. M., Cambien, F., Fruchart, J. C., & Ducimetiere, P. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37594-5 · Cited by 114 · see citing works

Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure

Sentı́, M., Romero, R., Pedro‐Botet, J., Pelegrí, A., Nogués, X., & Rubiés-Prat, J. (1992) · Kidney International · doi:10.1038/ki.1992.204 · Cited by 99 · see citing works

The genetics of serum lipid responsiveness to dietary interventions

Ordovás, J. M. (1999) · Proceedings of The Nutrition Society · doi:10.1079/pns19990023 · Cited by 95 · see citing works

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

Ferrari, R., Aguíar, C., Alegría, E., Bonadonna, R. C., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hâncu, N., et al. (2016) · European Heart Journal Supplements · doi:10.1093/eurheartj/suw009 · Cited by 96 · see citing works

Physical Activity and Lipoprotein Lipid Disorders

Berg, A., Frey, I., Baumstark, M. W., Halle, M., & Keul, J. (1994) · Sports Medicine · doi:10.2165/00007256-199417010-00002 · Cited by 94 · see citing works

Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families

Alaupovic, P. (1991) · Progress in Lipid Research · doi:10.1016/0163-7827(91)90008-s · Cited by 94 · see citing works

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D. C., Chen, M. M., Ooi, E. M. M., & Watts, G. F. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01678.x · Cited by 85 · see citing works

Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial

Otvos, J. D., SHALAUROVA, I. Y., Freedman, D. S., & Rosenson, R. S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00544-5 · Cited by 88 · see citing works

Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure

Attman, P.-O., Alaupovic, P., Tavella, M. J., & Knight‐Gibson, C. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.1.63 · Cited by 86 · see citing works

The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity

Saloma, V., Rasi, V., Pekkanen, J., Jauhiainen, M., Vahtera, E. M., Pietinen, P., KORHONEN, H. J., Kuulasmaa, K., & Ehnholm, C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90034-r · Cited by 84 · see citing works

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes

Gervaise, N., Garrigue, M. A., Lasfargues, G., & Lecomte, P. (2000) · Diabetologia · doi:10.1007/s001250051366 · Cited by 82 · see citing works

The concept of apolipoprotein-defined lipoprotein families and its clinical significance

Alaupovic, P. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0036-8 · Cited by 81 · see citing works

Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels

Wong, W.-M. R., Hawe, E., Li, L. K., Miller, G. J., Nicaud, V., Pennacchio, L. A., Humphries, S. E., & Talmud, P. J. (2003) · Circulation Research · doi:10.1161/01.res.0000069688.94567.7a · Cited by 81 · see citing works

The role of hypertriglyceridemia in atherosclerosis

Le, N., & Walter, M. F. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0006-7 · Cited by 79 · see citing works

Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.

Gotto, A. (1995) · Circulation · doi:10.1161/01.cir.92.3.646 · Cited by 87 · see citing works

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety

Kulik, A., & Ruel, M. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903188413 · Cited by 76 · see citing works

Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia

Campos, H., Perlov, D., Khoo, C., & Sacks, F. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31574-1 · Cited by 73 · see citing works

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk

Onat, A., & Hergenç, G. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.018 · Cited by 71 · see citing works

ApoC-III gene polymorphisms and risk of coronary artery disease

Olivieri, O., Stranieri, C., Bassi, A., Zaia, B., Girelli, D., Pizzolo, F., Trabetti, E., Cheng, S., Grow, M. A., Pignatti, P. F., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200145-jlr200 · Cited by 70 · see citing works

Is atherosclerosis caused by high cholesterol?

Ravnskov, U. (2002) · QJM · doi:10.1093/qjmed/95.6.397 · Cited by 68 · see citing works

Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women

Lamon‐Fava, S., Herrington, D. M., Reboussin, D. M., Sherman, M., Horvath, K. V., Cupples, L. A., White, C. C., Demissie, S., Schaefer, E. J., & Asztalos, B. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157123 · Cited by 68 · see citing works

The T Allele of the Hepatic Lipase Promoter Variant C−480T Is Associated With Increased Fasting Lipids and HDL and Increased Preprandial and Postprandial LpCIII:B

Jansen, H., Chu, G., Ehnholm, C., Dallongeville, J., Nicaud, V., & Talmud, P. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.303 · Cited by 68 · see citing works

Dyslipidemia of kidney disease

Attman, P., & Samuelsson, O. G. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832dd832 · Cited by 67 · see citing works

Associations Between Lipoproteins and the Progression of Coronary and Vein-Graft Atherosclerosis in a Controlled Trial With Gemfibrozil in Men With Low Baseline Levels of HDL Cholesterol

Syvänne, M., Nieminen, M. S., Frick, M. H., Kauma, H., Majahalme, S. K., Virtanen, V., Kesäniemi, Y. A., Pasternack, A. I., Ehnholm, C., & Taskinen, M. (1998) · Circulation · doi:10.1161/01.cir.98.19.1993 · Cited by 67 · see citing works

Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function

Båvenholm, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0752 · Cited by 67 · see citing works

Apolipoprotein C‐III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

Olivieri, O., Martinelli, N., Girelli, D., Pizzolo, F., Friso, S., Beltrame, F., Lotto, V., Annarumma, L., & Corrocher, R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03720.x · Cited by 64 · see citing works

Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency

Bijvoet, S. M., Gagné, S., Moorjani, S., Gagné, C., Henderson, H., Fruchart, J., Dallongeville, J., Alaupovic, P., Prins, M. H., Kastelein, J. J. P., et al. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37605-7 · Cited by 64 · see citing works

Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia

Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Rodriguez, C., Steiner, G. A., Mamer, O., & Davignon, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.011 · Cited by 62 · see citing works

Triglycerides as a risk factor for coronary artery disease

Sprecher, D. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00953-9 · Cited by 60 · see citing works

The compositional abnormalities of lipoproteins in diabetic renal failure

Attman, P.-O., Knight‐Gibson, C., Tavella, M. J., Samuelsson, O. G., & Alaupovic, P. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.11.2833 · Cited by 59 · see citing works

Retardation and arrest of progression or regression of coronary artery disease: a review.

Vos, J., de Feyter, P., Simoons, M., Tijssen, J. G., & Deckers, J. W. (1993) · Progress in cardiovascular diseases · doi:10.1016/0033-0620(93)90028-c · Cited by 62 · see citing works

Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease

Koren, E., Corder, C. N., Mueller, G., Centurion, H., Hallum, G., Fesmire, J., McConathy, W. D., & Alaupovic, P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05791-9 · Cited by 56 · see citing works

HDL and triglyceride as therapeutic targets

Fruchart, J., & Duriez, P. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200212000-00003 · Cited by 56 · see citing works

Serum apolipoprotein C‐III in high‐density lipoprotein: a key diabetogenic risk factor in Turks

Onat, A., Hergenç, G., Ayhan, E., Uğur, M., Kaya, H., Tuncer, M., & Can, G. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02814.x · Cited by 55 · see citing works

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

Alaupovic, P., Heinonen, T. M., Shurzinske, L., & Black, D. M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00119-6 · Cited by 54 · see citing works

Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial

Karim, R., Mack, W. J., Lobo, R. A., Hwang, J., Liu, C., Liu, C.-H., Sevanian, A., & Hodis, H. N. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000153934.76086.a4 · Cited by 52 · see citing works

Complexities of plasma apolipoprotein C-III metabolism

Frank M. Sacks, E. B., Zheng, C., & Jeffrey S. Cohn, E. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.e015701 · Cited by 51 · see citing works

Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes

Dallinga‐Thie, G. M., Berk-Planken, I. I. L., Bootsma, A. H., Jansen, H., & on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1358 · Cited by 51 · see citing works

Associations of genotypes at the apolipoprotein AI‐CIII‐AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses

Peacock, R. E., Hamsten, A., Johansson, J., Nilsson‐Ehle, P., & Humphries, S. E. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04159.x · Cited by 51 · see citing works

Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and “insulin-resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction

Olivieri, O., Martinelli, N., Sandri, M., Bassi, A., Guarini, P., Trabetti, E., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.040477 · Cited by 50 · see citing works

Prediction of Angiographic Change in Native Human Coronary Arteries and Aortocoronary Bypass Grafts Lipid and Nonlipid

Hp, C., & Azen, S. P. (2016)

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654 · see citing works

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321 · see citing works

Associations Between Lipoproteins and the Progression of Coronary and Vein-Graft Atherosclerosis in a Controlled Trial With Gemfibrozil in Men With Low Baseline Levels of HDL Cholesterol

Syvänne, M., Nieminen, M. S., Frick, M. H., Kauma, H., Majahalme, S. K., Virtanen, V., Kesäniemi, Y. A., Pasternack, A. I., Ehnholm, C., & Taskinen, M. (1998) · Circulation · doi:10.1161/01.cir.98.19.1993 · Cited by 67 · see citing works

The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation

CAMPEAU, L. A., Enjalbert, M., Lespérance, J., Bourassa, M. G., Kwiterovich, P. O., Wacholder, S., & Sniderman, A. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411223112101 · Cited by 621 · see citing works